Literature DB >> 24393232

Prevalence, awareness, treatment and control of dyslipidemia among adults in northwestern China: the cardiovascular risk survey.

Jun-yi Luo, Yi-Tong Ma1, Zi-xiang Yu, Yi-Ning Yang, Xiang Xie, Xiang Ma, Fen Liu, Xiao-mei Li, Bang-dang Chen.   

Abstract

AIM: The aim of this study was to estimate the prevalence, awareness, treatment, and control of dyslipidemia in Xinjiang, China.
METHOD: Stratified sampling method was used to select a representative sample of the general population including Chinese Han, Uygur, and Kazak in this geographic area. Seven cities were chosen. Based on the government records of registered residences, one participant was randomly selected from each household. The eligibility criterion for the study was ≥ 35 years of age.
RESULTS: A total of 14,618 participants (5,757 Han, 4,767 Uygur, and 4,094 Kazak), were randomly selected from 26 villages in 7 cities. The prevalence of dyslipidemia was 52.72% in the all participants. The prevalence of dyslipidemia was higher in Han than that in the other two ethnic (58.58% in Han, 48.27% in Uygur, and 49.60% in Kazak, P < 0.000). The prevalence of dyslipidemia was higher in men than that in women (56.4% vs. 49.3%, P < 0.000). Among the participants with dyslipidemia, the proportion of those who aware, treat, control of dyslipidemia were 53.67%, 22.51%, 17.09% in Han, 42.19%, 27.78%, 16.20% in Uygur, 37.02%, 21.11%, 17.77% in Kazak.
CONCLUSION: Dyslipidemia is highly prevalent in Xinjiang. The proportion of participants with dyslipidemia who were aware, treated, and controlled is unacceptably low. These results underscore the urgent need to develop national strategies to improve the prevention, detection, and treatment of dyslipidemia in Xinjiang.

Entities:  

Mesh:

Year:  2014        PMID: 24393232      PMCID: PMC3895843          DOI: 10.1186/1476-511X-13-4

Source DB:  PubMed          Journal:  Lipids Health Dis        ISSN: 1476-511X            Impact factor:   3.876


Introduction

Cardiovascular disease (CVD) is one of the first leading contributor to mortality both in developed and developing countries [1]. It has been estimated that aging and population growth will increase CVD by more than a half over the next 20 years in China [2]. This will bring such a enormous burden for Chinese economy. Dyslipidemia, an independent and modifiable risk factor has a causal role in the pathogenesis of CVD [3]. With the economic growth and associated lifestyle changes, studies demonstrated that the prevalence of dyslipidemia has increased significantly during the last decade, however the awareness, treatment and control of dyslipidemia was low in China [4-6]. These above studies mainly enrolled Chinese Han participants. The condition of dyslipidemia in minorities of China was incompletely investigated. Xinjiang is an autonomous minority ethnic region of the People’s Republic of China in the northwest of the country. It is the largest Chinese administrative division and spans over 1.6 million km2 which takes up about one sixth of the country’s territory. The Tianshan mountains divide Xinjiang into two parts, the north is called the northern Xinjiang, the south is called the southern Xinjiang. Several studies had reported the prevalence, awareness, treatment and control of dyslipidemia among adults in Xinjiang [7-9]. Nevertheless, the samples in each study were small or the participants were from the northern or the southern area only. So, those studies couldn’t represent the status of dyslipidemia in the whole region of Xinjiang. To better understand the status of dyslipidemia in Xinjiang, our team did a cross-sectional study called the Cardiovascular Risk Survey (CRS) between October 2007 and March 2010, which was expected to provide a comprehensive update results for the previous studies.

Methods

Ethnic statement

This study was conducted according to the standards of the Declaration of Helsinki. Written informed consent was acquired from each participant prior to enrollment. Ethics approval was obtained from the Ethics Committee of the First Affiliated Hospital of Xinjiang Medical University.

Study subjects

A multi-ethnic, community-based, cross-sectional study involving cardiovascular risk factors (called CRS) was conducted in Xinjiang, northwestern China between October 2007 and March 2010. The study has been described in detail previously [10-13]. Briefly, The CRS was designed to determine the prevalence, incidence, and risk factors of CVD and to determine the genetic and environmental contributions to atherosclerosis, coronary artery disease, and cerebral infarction in the population of Xinjiang, northwestern China. There were approximate 19.63 million residents lived in the beautiful place. Among them the Uygur accounted for 45.73% of the population, the Han accounts for 39.75% of the population, and the Kazak accounted for 7.04% of the population (data from 5th census of China). We used a stratified sampling method to select a representative sample of the general population of the three main ethnics (Han, Uygur, and Kazak) residing in Xinjiang. Seven cities [northern Xinjiang (Urumqi, Karamay, Yili and Fukang), southern Xinjiang (Khotan, Turpan, and Shanshan)] were selected. Based on the government records of registered residences, one participant was randomly selected from each household. The eligibility criterion for the study was ≥ 35 years of age. A total of 14,618 participants (5,757 Han, 4,767 Uygur, and 4,094 Kazak) were randomly selected from 26 villages of the 7 cities and were invited to participate in our study. Participants with incomplete data were excluded, thus 14, 113 participants (5,582 Han, 4,616 Uygur, and 3,915 Kazak) were analyzed in this study.

Data collection

Questionnaire interview

Data were collected in examination centers at the local hospitals in the participants’ residential areas. During the clinic or home visit, trained researchers asked the participants questions from a standard questionnaire providing information on demographic variables, such as age, gender, ethnicity, address, education, occupation, family income, a known diagnosis of dyslipidemia, and current treatment of dyslipidemia.

Laboratory assay

During the interview, a 5-mL fasting blood sample (fasting ≥ 8 hours) was collected in an EDTA vacutainer tube. Serum was separated from the samples within 30 min and stored at –80°C immediately after processing. We measured the concentrations of triglycerides (TG), total cholesterol (TC), and high density lipoprotein-cholesterol (HDL-C), and low density lipoprotein-cholesterol (LDL-C) using a Dimension AR/AVL Clinical Chemistry System (Newark, NJ, USA) in the Clinical Laboratory Department of the First Affiliated Hospital of Xinjiang Medical University.

Definitions

The definition of dyslipidemia was based on the guideline of Chinese Prevention and Treatment of Dyslipidemia in adults [14]. Thus, a subject was considered as dyslipidemia if his total cholesterol ≥ 6.22 mmol/l (240 mg/dl) and/or his LDL-C ≥ 4.14 mmol/l (160 mg/dl) and/or HDL-C < 1.04 mmol/l (40 mg/dl), and/or triglyceride ≥ 2.26 mmol/l (200 mg/dl) and/or he was taking a hypolipidemia drug. Awareness of dyslipidemia was defined as a self-report of any prior diagnosis of dyslipidemia by a medical doctor. Treatment of dyslipidemia was defined as use of pharmacological treatment to manage dyslipidemia during the previous 2 weeks. Participants were considered to have controlled dyslipidemia if their serum concentrate of TC < 6.22 mmol/l, LDL-C < 1.14 mmol/l, HDL-C ≥ 1.04 mmol/l, and TG < 2.26 mmol/l after treatment.

Statistical analysis

All of the questionnaire data were double-entered and cross-validated using EpiData version 3.1 (EpiData Association, Odense, Denmark). Data analyses were conducted using a commercially available statistical software package (SPSS for Windows, version 17.0, SPSS, Chicago, IL). We stratified our analyses by age, sex, and ethnicity (Han, Uygur, and Kazak). Continuous variables were given as mean ± standard deviation and the categorical variables were given as percentages. One-way ANOVA was used to compare the means in numerical data. χ2-test was used to explore associations in categorical data. Logistic regression analysis was used to assess the contribution of smoking and alcohol to the prevalence of dyslipidemia. All P-value were two-side and significant difference was set at P-values < 0.05.

Results

Participant characteristics

The participants included in these analyses, 39.55% were Han, 32.71% were Uygur, and 27.74% were Kazak. The general characteristics of the participants are shown in Table  1.
Table 1

Participation characteristics in adult population , aged ≥ 35 years, in Xinjiang

 
Mean ± SD or No. (%)
Han
Uygur
Kazak
 (n = 5582)(n = 4616)(n = 3915)
Age, years
52.6 ± 12.7
50.7 ± 13.0
48.7 ± 11.6
Height, cm
163.2 ± 8.5
159.8 ± 8.5
162.7 ± 8.7
Weight, kg
67.2 ± 12.0
66.1 ± 12.9
70.6 ± 15.1
Women, n (%)
2889 (51.8)
2669 (57.8)
2021 (51.6)
Smoking, n (%)
1749 (31.4)
871 (18.9)
1396 (35.7)
Alcohol, n (%)
1057 (18.9)
456 (9.9)
571 (14.6)
BMI, kg/m2
25.1 ± 3.5
25.8 ± 4.4
26.6 ± 4.8
SBP, mmHg
132.9 ± 19.9
131.5 ± 21.2
140.4 ± 25.1
DBP, mmHg
85.1 ± 15.5
80.1 ± 14.9
88.5 ± 19.7
Waist circumference, cm
86.8 ± 10.3
88.2 ± 12.3
88.3 ± 13.4
Hip circumference, cm
95.8 ± 7.4
97.7 ± 10.0
99.6 ± 9.7
TG, (mmol/L)
1.7 ± 1.4
1.6 ± 1.2
1.2 ± 0.9
TC, (mmol/L)
4.7 ± 1.1
4.4 ± 1.1
4.8 ± 1.2
HDL-C, (mmol/L)
1.3 ± 0.5
1.3 ± 0.5
1.3 ± 0.4
LDL-C, (mmol/L)
2.9 ± 0.9
2.9 ± 0.9
2.9 ± 0.9
Blood Glucose, (mmol/L)5.3 ± 1.84.9 ± 1.75.1 ± 1.5

Note: BMI, body mass index, SBP, systolic blood pressure, DBP, diastolic blood pressure, TG, triglycerides, TC, total cholesterol, HDL-C, high density lipoprotein-cholesterol, LDL-C, low density lipoprotein-cholesterol.

Participation characteristics in adult population , aged ≥ 35 years, in Xinjiang Note: BMI, body mass index, SBP, systolic blood pressure, DBP, diastolic blood pressure, TG, triglycerides, TC, total cholesterol, HDL-C, high density lipoprotein-cholesterol, LDL-C, low density lipoprotein-cholesterol.

Prevalence of dyslipidemia

Table  2 shows the prevalence of dyslipemia of the participations. The prevalence of dyslipidemia was 52.72% in the total participants. The prevalence of dyslipidemia was significant higher in Han than that in the other two ethnic (P < 0.000). The prevalence of dyslipidemia was higher in men than that in women (P < 0.000). For total and women, the prevalence of dyslipidemia was significantly lower in the 35-54 years old group than that in 55-88 years old group among the three ethnic. For men, the prevalence of dyslipidemia was significantly higher in the 35-54 years old group than that in 55-88 years old group in the Han and Uygur ethnic. But for Kazak ethnic, no significant difference was found between the two age groups.
Table 2

Prevalence of dyslipidemia in adult population , aged ≥ 35 years, in Xinjiang

Age, year
Men
Women
Total
 NDyslipidemia [n, (%)]NDyslipidemia [n, (%)]NDyslipidemia [n, (%)]
Han ethnic
35-54
1628
1116 (68.6)
1641
681 (41.5)
3260
1797 (55.1)
55-88
1065
637 (59.8)
1248
836 (67.0)
2313
1473 (63.7)
Total
2693
1753 (65.1)
2889
1517 (52.5)
5582
3270 (58.6)
P value
 
<0.001
 
<0.001
 
<0.001
Uygur ethnic
35-54
1071
529 (49.4)
1761
787 (44.7)
2832
1316 (46.5)
55-88
876
384 (43.8)
908
528 (58.2)
1784
912 (51.1)
Total
1974
913 (46.3)
2669
1315 (49.3)
4616
2228 (48.3)
P value
 
0.015
 
<0.001
 
0.002
Kazak ethnic
35-54
1287
699 (54.3)
1450
571 (39.4)
2737
1270 (46.4)
55-88
607
336 (55.4)
571
336 (58.8)
1178
672 (57.1)
Total
1894
1035 (54.7)
2021
907 (44.9)
3915
1942 (49.6)
P value 0.671 <0.001 <0.001
Prevalence of dyslipidemia in adult population , aged ≥ 35 years, in Xinjiang

Smoking and drinking related to the prevalence of dyslipidemia

The Table  3 shows that the prevalence of dyslipidemia was significantly related to smoking (ex-smoker and current smoker have significantly higher risk for dyslipidemia than that the person who never smoked), alcohol consumption (current drinker has significantly higher risk for dyslipidemia than that the person who never drunk).
Table 3

smoking and alcohol consumption to the dyslipidemia in Xinjiang area

Risk factorsORLower of 95.0% CIUpper of 95.0% CIP value
Smoking status
Ex-smoker
2.2
2.0
2.3
P < 0.001
Current smoker
4.0
3.6
4.3
P < 0.001
Alcohol status
Ex-drinker
1.1
0.9
1.2
0.405
Current drinker1.31.21.4P < 0.001
smoking and alcohol consumption to the dyslipidemia in Xinjiang area

Awareness, treatment, and control of dyslipidemia

Among the participants who with dyslipidemia, the proportion of those who were aware of their condition was highest in Han than the other two ethnics (P < 0.001). The percentage of participants who was treated for dyslipidemia among the three ethnics was higher Uygur than that in Han or Kazak (P < 0.001). For the percentage of control of dyslipidemia, no significant difference was found among the three ethnics (Figure  1).
Figure 1

The percentage of awareness, treatment, control of dyslipidemia among the three ethnics in Xinjiang.

The percentage of awareness, treatment, control of dyslipidemia among the three ethnics in Xinjiang. Table  4 shows the percentage of awareness, treatment, and control of dyslipidemia in the subgroups classified by age and sex in each ethnic. In Han, men of the younger age group (ages 35-54) had a significantly higher awareness of dyslipidemia than that in younger age women (58.96% vs. 49.05%, P<0.001). Nevertheless, the younger men had a significantly lower rate of control of dyslipidemia than that in women (13.80% vs. 19.53%, P = 0.001). Additionally, men of the older age group (ages 55-88) had a significantly lower treatment of dyslipidemia than that in older age women (22.92% vs. 27.75%, P = 0.035). However, the older men had a significantly higher rate of control of dyslipidemia than that in older women (21.35% vs. 16.27%, P = 0.013). Significant differences of the proportion of awareness (58.96% vs.53.38% P = 0.023) and control (13.8% vs. 21.35%, P<0.001) were found between the younger age group and the older age group in men. In addition, a significant difference of treatment of dyslipidemia was also found between the two age group in women (20.85% for younger group, 27.75% for older group, P = 0.002).
Table 4

Awareness, treatment, control of dyslipidemia in adult population , aged ≥ 35 years, in Xinjiang

Age, yearHan [n, (%)]
P valueUygur [n, (%)]
P valueKazak [n, (%)]
P value
MenWomenMenWomenMenWomen
Awareness
 35-54
658 (59.0)
334 (49.1)
<0.001
216 (40.8)
336 (42.7)
0.502
269 (38.5)
204 (35.7)
0.312
 55-88
340 (53.4)
423 (50.6)
0.291
164 (42.7)
224 (42.4)
0.932
133 (39.6)
113 (33.6)
0.109
P value
0.023
0.547
 
0.057
0.923
 
0.734
0.523
 
Treatment
 35-54
216 (19.4)
142 (20.9)
0.441
106 (20.0)
234 (29.7)
<0.001
149 (21.3)
108 (18.9)
0.289
 55-88
146 (22.9)
232 (27.8)
0.035
111 (28.9)
168 (31.8)
0.346
85 (25.3)
68 (20.2)
0.118
P value
0.076
0.002
 
0.02
0.421
 
0.152
0.626
 
Control
 35-54
154 (13.8)
133 (19.5)
0.001
80 (15.1)
127 (16.1)
0.62
134 (19.2)
106 (18.6)
0.784
 55-88
136 (21.4)
136 (16.3)
0.013
75 (19.5)
79 (15.0)
0.069
61 (18.2)
44 (13.1)
0.071
P value<0.0010.098 0.080.565 0.6960.032 
Awareness, treatment, control of dyslipidemia in adult population , aged ≥ 35 years, in Xinjiang In Uygur, no significant differences of awareness or control of dyslipidemia was found in each subgroup. Nevertheless, the younger age women had a significantly higher treatment of dyslipidemia than that in younger age men (29.73% vs. 20.04%, P<0.001). A significant difference of treatment of dyslipidemia was also found between the two age group in men (20.04% for younger group, 28.91% for older group, P = 0.02). In Kazak, we only found that the younger age women had a significantly higher control of dyslipidemia than that in the older age women (18.56% vs. 13.10%, P = 0.032).

Discussion

The present study was aimed to determine the prevalence rate of dyslipidemia, and the awareness, treatment, and control of dyslipidemia in Xinjiang (northwestern China). We found that the prevalence of dyslipidemia was high in this area. The Chinese national nutrition and health survey (CNHS) indicated that the prevalence of dyslipidemia was 18.6% in the Chinese national average in 2002 [15,16]. Wu et al. reported that the prevalence of dyslipidemia of the population in Shanghai was 36.5% in 2003 [5]. Studies reported that the prevalence of dyslipidemia in the Beijing adult population was 30.3% in 2007 and 35.4% in 2008 [4,17]. It was reported that economic growth and associated changes in lifestyle and diet might contribute to the increase of the prevalence of dyslipidemia in the Chinese population. However, it was obvious that the prevalence of dyslipidemia in the three ethnic in Xinjiang were significantly higher than that in the other areas of China even the economically developed areas in China. This may be associated with the residents in Xinjiang were characterized by eating more animal fat, drinking strong wine, with a higher salt intake (>20 g per day), and consuming less grain, fresh vegetables, beans, bean products, and unsaturated fatty acids [18]. A significant difference of the prevalence of dyslipidemia was also observed among the subgroups classified by the sex and the age. The prevalence was higher in men that in women among participants under age 55, but the results were reversed in the participants older than 55 years. The phenomenon was consistent with the results of the Wu et al. [5]. The increased prevalence among older women may be associated to differences in estrogen levels between pre- and post-menopausal women [19]. In Xinjiang area, higher levels of dyslipidemia was found among the smokers (ex and current) and current drinkers. Those results are in agreement with other sources [20-22], and indicate the clustering of common cardiovascular risk factors within these populations. We also observed that the prevalence of dyslipidemia in the Han ethnic was significantly higher than that in the Uygur and Kazak ethnic, the mechanisms underlying this phenomenon are not clear. It is believed that the different dietary habits among the three ethnics may play an important role [23]. The Han population consisted mainly of animal fats, such as pork, and the principal food was carbohydrate, especially refined flour or rice, whereas the Uygur and Kazak people subsist chiefly on beef, mutton, and milk products. Furthermore, the Uygur and Kazak population were characterized by eating onion, tea, yogurt, and nuts, which can promote lipid absorption, digestion, and decomposition [24]. Moreover, most of the Uygur and Kazak participations lived in cold and semiarid regions, they need more energy to cope with the cold whether than the Han population who most of them lived in the warm and plain regions. In addition, different of genetic backgrounds and gene-environment interactions might also be important factors underlying the different prevalence of dyslipidemia among the three ethnic. The prevalence of dyslipidemia in the Xinjiang area was surprisingly high, but the rate of awareness, treatment, and control of dyslipidemia was significantly low in the participations based on the present study. For Han ethnic, the percentage of awareness, treatment, and control of participations with dyslipidemia was 53.67%, 22.51%, and 17.09%, respectively. For Uygur ethnic, the percentage was 42.19%, 27.78%, 16.20%, and for Kazak ethnic, the percentage was 37.02%, 21.11%, 17.77%. We found that the awareness and treatment of dyslipidemia were significantly higher in our study than that in the previous studies [4,6,25]. However, the control of dyslipidemia in our study was unacceptably low among the all participants who with dyslipidemia. It meant that the dyslipidemia has become one of the important health risk factors in the Xinjiang. Therefore, a national dsylipidemia education program that to promote community- and clinic-based serum lipid screening was urgently needed. Physicians must regularly check their patients’ serum lipids, and a more aggressive serum lipid-lowering goal and strategy must be utilized. Our study was a large, comprehensive epidemiologic evaluation of ethnic and sex difference in dyslipidemia, but it did have some limitations. Firstly, the CRS was a cross-sectional study, potential recall bias of self-reported might affect the condition of dyslipidemia in Xinjiang. Secondly, our study enrolled the three main ethnics (Han, Uygur, Kazak) which consisted more than 90 percentage of the population in Xinjiang. Nevertheless, there were nearly more than 10 ethnic minorities lived in Xinjiang generation by generation, the status of dyslipidemia was still unclear.

Conclusion

In conclusion, our study provides reliable and up-to-date information on dyslipdemia in the adult of Xinjiang. More than half of the participants had dyslipidemia in Xinjiang, it was significantly higher than the Chinese national average rate. But the proportion of awareness, treatment, and control was unacceptably low among the three ethnic populations.

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

Conceived and designed the experiments: J-YL, Y-TM. Performed the experiments: J-YL, Z-XY, Y-NY. Analyzed the data: XX, XM. Contributed reagents/materials/analysis tools: FL, X-ML, B-DC. Wrote the paper: J-YL, Y-TM. All authors read and approved the final manuscript.
  25 in total

1.  Awareness, treatment and control of hyperlipidaemia in middle-aged men in France and northern ireland in 1991-1993: the PRIME study. Prospective epidemiological study of myocardial infarction.

Authors:  Pedro Marques-Vidal; Dominique Arveiler; Alun Evans; Philippe Amouyel; Jean Ferrieres; Gérald Luc; Pierre Ducimetière
Journal:  Acta Cardiol       Date:  2002-04       Impact factor: 1.718

2.  [Epidemiological survey of lipid levels and factors in Kazakan people over 30-year old in Fukang of Xinjiang].

Authors:  Deng-pan Liang; Xiao-guang Yao; Nan-fang Li; De-lian Zhang; Yan-ying Guo; Li Lin; Ling Zhou; Wen-chang Li; Zhi-tao Yan; Hong-mei Wang; Wen-li Luo; Jian-hang Chang
Journal:  Zhonghua Yu Fang Yi Xue Za Zhi       Date:  2011-05

3.  Future cardiovascular disease in china: markov model and risk factor scenario projections from the coronary heart disease policy model-china.

Authors:  Andrew Moran; Dongfeng Gu; Dong Zhao; Pamela Coxson; Y Claire Wang; Chung-Shiuan Chen; Jing Liu; Jun Cheng; Kirsten Bibbins-Domingo; Yu-Ming Shen; Jiang He; Lee Goldman
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2010-05-04

Review 4.  Diabetes, hyperlipidemia, and coronary artery disease.

Authors:  S M Haffner
Journal:  Am J Cardiol       Date:  1999-05-13       Impact factor: 2.778

5.  Mortality by cause for eight regions of the world: Global Burden of Disease Study.

Authors:  C J Murray; A D Lopez
Journal:  Lancet       Date:  1997-05-03       Impact factor: 79.321

6.  Clustering of risk habits in young adults. The Cardiovascular Risk in Young Finns Study.

Authors:  O T Raitakari; M Leino; K Räkkönen; K V Porkka; S Taimela; L Räsänen; J S Viikari
Journal:  Am J Epidemiol       Date:  1995-07-01       Impact factor: 4.897

7.  Alcohol consumption and ankle-to-brachial index: results from the Cardiovascular Risk Survey.

Authors:  Xiang Xie; Yi-Tong Ma; Yi-Ning Yang; Xiao-Mei Li; Fen Liu; Ding Huang; Zhen-Yan Fu; Xiang Ma; Bang-Dang Chen; Ying Huang
Journal:  PLoS One       Date:  2010-12-02       Impact factor: 3.240

8.  Serum total and lipoprotein cholesterol levels and awareness, treatment, and control of hypercholesterolemia in China.

Authors:  Jiang He; Dongfeng Gu; Kristi Reynolds; Xigui Wu; Paul Muntner; Jiangong Zhao; Jing Chen; Donghai Liu; Jingping Mo; Paul K Whelton
Journal:  Circulation       Date:  2004-07-06       Impact factor: 29.690

9.  Blood lipid profile and prevalence of dyslipidemia in Chinese adults.

Authors:  Wen-Hua Zhao; Jian Zhang; Yi Zhai; Yue You; Qing-Qing Man; Chun-Rong Wang; Hong Li; Ying Li; Xiao-Guang Yang
Journal:  Biomed Environ Sci       Date:  2007-08       Impact factor: 3.118

10.  Type 2 diabetes in Xinjiang Uygur autonomous region, China.

Authors:  Yi-Ning Yang; Xiang Xie; Yi-Tong Ma; Xiao-Mei Li; Zhen-Yan Fu; Xiang Ma; Ding Huang; Bang-Dang Chen; Fen Liu; Ying Huang; Cheng Liu; Ying-Ying Zheng; Gulinaer Baituola; Zi-Xiang Yu; You Chen
Journal:  PLoS One       Date:  2012-04-10       Impact factor: 3.240

View more
  23 in total

1.  Association of NCOA2 gene polymorphisms with obesity and dyslipidemia in the Chinese Han population.

Authors:  Yuping Lu; Tsadik Ghebreamlak Habtetsion; Yong Li; Huiping Zhang; Yichun Qiao; Mingxi Yu; Yuan Tang; Qing Zhen; Yi Cheng; Yawen Liu
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

2.  Prevalence of Dyslipidemia in Tibetan Monks from Gansu Province, Northwest China.

Authors:  Yan Fang; Xing-Hui Li; Yan Qiao; Nan Wang; Ping Xie; Gang Zhou; Peng Su; Hui-Yuan Ma; Ji-Yang Song
Journal:  Open Life Sci       Date:  2020-05-07       Impact factor: 0.938

3.  An Evaluation on the Effect of Health Education and of Low-Dose Statin in Dyslipidemia among Low-Income Rural Uyghur Adults in Far Western China: A Comprehensive Intervention Study.

Authors:  Jiaolong Ma; Shuxia Guo; Rulin Ma; Jingyu Zhang; Jiaming Liu; Yusong Ding; Mei Zhang; Heng Guo; Jia He; Yizhong Yan; Lati Mu; Shugang Li; Qiang Niu
Journal:  Int J Environ Res Public Health       Date:  2015-09-11       Impact factor: 3.390

4.  Serum lipids and associated factors of dyslipidemia in the adult population in Shenzhen.

Authors:  Wen-Qing Ni; Xiao-Li Liu; Zhi-Peng Zhuo; Xue-Li Yuan; Jin-Ping Song; Hong-Shan Chi; Jian Xu
Journal:  Lipids Health Dis       Date:  2015-07-14       Impact factor: 3.876

5.  Serum vitamin D is low and inversely associated with LDL cholesterol in the Kazak ethnic population: a cross-sectional study.

Authors:  Ming Chen Zhang; Hai Xia Li; Hai Ming Liu; Hong Lei; Lu Han; Ming Gao; Jiang Feng Mao; Xin Juan Xu
Journal:  Med Sci Monit       Date:  2014-07-23

6.  Six-year changes in the prevalence of obesity and obesity-related diseases in Northeastern China from 2007 to 2013.

Authors:  Jing Wu; Hongqin Xu; Xiuting He; Yi Yuan; Chunyan Wang; Jie Sun; Shumei He; Junqi Niu
Journal:  Sci Rep       Date:  2017-01-27       Impact factor: 4.379

7.  Awareness, knowledge and practice of dyslipidaemia management among postgraduate primary care trainees in Malaysia: a cross-sectional study.

Authors:  Abdul Hadi Said; Yook Chin Chia
Journal:  BMJ Open       Date:  2017-03-01       Impact factor: 2.692

8.  Polymorphisms of rs2483205 and rs562556 in the PCSK9 gene are associated with coronary artery disease and cardiovascular risk factors.

Authors:  Min-Tao Gai; Dilare Adi; Xiao-Cui Chen; Fen Liu; Xiang Xie; Yi-Ning Yang; Xiao-Ming Gao; Xiang Ma; Zhen-Yan Fu; Yi-Tong Ma; Bang-Dang Chen
Journal:  Sci Rep       Date:  2021-06-01       Impact factor: 4.379

9.  Dyslipidemia awareness, treatment, control and influence factors among adults in the Jilin province in China: a cross-sectional study.

Authors:  Huan He; Ya-qin Yu; Yong Li; Chang-gui Kou; Bo Li; Yu-chun Tao; Qing Zhen; Chang Wang; Joseph Sam Kanu; Xu-feng Huang; Mei Han; Ya-wen Liu
Journal:  Lipids Health Dis       Date:  2014-08-03       Impact factor: 3.876

10.  Prevalence of dyslipidemia and associated factors among the hypertensive population from rural Northeast China.

Authors:  Shasha Yu; Hongmei Yang; Xiaofan Guo; Xingang Zhang; Liqiang Zheng; Yingxian Sun
Journal:  BMC Public Health       Date:  2015-11-21       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.